Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Experts
For Die Hard Investors: Luke’s trio of high-risk small caps Most Likely to Survive Nakatomi Plaza in 2024
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
News
ASX Small Caps and IPO Weekly Wrap: A Benchmark bonanza, but harder to pick than a broken nose
Health & Biotech
ScoPo’s Powerplays: ASX healthcare up as ‘rising tide lifts all boats’
News
In Case You Missed It: Heavy mineral sands, a biotech takeover and some gold
Health & Biotech
ASX Health Stocks: Mach7 signs $10m deal; Volpara agrees to $300m takeover from South Korean outfit
News
Top 10 at 11: Volpara’s breast cancer detection tech is hot property, lithium has its ups and downs
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat as a pancake but hopes still of Christmas rally
Health & Biotech
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
News
In Case You Missed It: Lithium and gold project acquisitions and cheaper boron nitride nanotubes
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, CSL recovers after sinking on latest Novo Nordisk news
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but Dimerix up 150% on drug licensing deal
Explainers
ASX cancer stocks guide: Here’s everything you need to know
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
News
Why a free-falling Aussie dollar could be good news for investors and these ASX stocks
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Volpara records third quarter of positive cashflow
Tech
